Table 1.
Distribution of Baseline Characteristics in Study Population
| Characteristic | |
| Age (years) | 49.9 (0.55) |
| Male/female | 87 (44)/113 (56) |
| BMI (kg/m2) | 28.3 (4.5) |
| Diabetes mellitus | 19 (10) |
| Smoker | 64 (32) |
| Dyslipidemia | 142 (71) |
| Lipid‐lowering treatment | 118 (59) |
| Biochemical markers | |
| Glucose (mg/dl) | 95.4 (2.2) |
| Creatinine (mg/dl) | 0.82 (0.01) |
| Urea (mg/dl) | 32.2 (1.2) |
| SGOT (U/l) | 28.4 (0.8) |
| SGPT (U/l) | 32.3 (2.3) |
| GGT (U/l) | 22.8 (1.1) |
| Cholesterol (mg/dl) | 187.8 (2.4) |
| HDL – cholesterol (mg/dL) | 41.8 (0.7) |
| LDL – cholesterol (mg/dl) | 121.4 (2.2) |
| Triglycerides (mg/dl) | 107.7 (74) |
| Uric acid (mg/dl) | 5.0 (8.1) |
| Cardiovascular risk factors | |
| Haluronic acid (ng/ml) | 65.5 (2.6) |
| Framingham risk score (%) | 2 (5) |
| Framingham risk (Low/Intermediate) | 168/32 |
| hsCRP (mg/l) | 0.13 (0.2) |
| Hematological markers | |
| Hemoglobin (g/dl) | 13.6 (0.58) |
| White blood cells (109/l) | 7.239 (128) |
| Platelets (109/l) | 238 (4) |
For categorical: n (%); for continuous: mean (SEM), except for BMI, hsCRP, triglycerides, Framingham risk score, which are expressed as median (interquartile range).